Centro de Investigaciones Metabólicas (CINME) S.A. - CABA, Buenos Aires
CINME abre sus puertas en el 2007. Su misión es mejorar la calidad de vida de sus pacientes, a través de la atención médica asistencial humana e integral, siendo un centro educador para la comunidad y aportando datos cualitativos al avance científico en el marco de la investigación clínica. Hemos incorporado nuevas áreas terapéuticas en el campo de la salud, buscando ser en cada una un centro modelo para el diagnóstico y tratamiento de enfermedades, y al mismo tiempo de referencia en el campo de la investigación clínica. Teniendo como ideal la excelencia, hemos hecho especial énfasis en los procesos que nos aportan altos estándares de calidad en nuestro trabajo. Por ello, en el 2019 certificamos en calidad en los procesos de investigación clínica a través de IRAM-ISO 9001-2015.Viamonte 2278, C1056ABJ Cdad. Autónoma de Buenos Aires, Argentina
Websitehttp://www.cinme.com.ar
Select an option
I am a doctor
I am a sponsor
Specializations
Dermatitis atópica
Diabetes
Hepatitis autoinmune
Colitis ulcerosa
Enfermedad de Crohn
Fibrosis pulmonar
Fibrosis pulmonar idiopática
Cardiovascular
Nefropatía
Our team
Medical staff
Gisela Burattini
Daniela Saravia
Lucia Escalona Barrios
Emilia Pastormerlo
Luisa Ramallo
Solana Alderete Morillo
Camila Rotta
Gabriela Romero
Catalina Hermida
Ana Maria Freuler
Nerina Samanta Rodriguez Giambagli
Gonzalo Saenz
Alejandra Romeo
Angela Romero Zarante
Mónica Rondinón
Liliana González
Mariana Abal
Ricardo Galimberti
Maria Laura Galimberti
Griselda Russo
María Otaola
Maria Otaola
Fernando Halac
Raquel Analia González
Estanislao Jesus Gomez
Maria Julia Garay
Gonzalo Saenz
Alberto Casey
Alberto Lorenzo Casey
Daniela Camargo
Daniel Seinhart
Federico Carlos Perez Manghi
Maria de Lourdes Figuerola
María Margarita Anders
Estanislao Gómez
Adriana Ellenberg
Mariana Paula Blas
Maria Otaola
Lucas Manghi
Open studies
Pulmonary fibrosis
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis - ALOFT-IPF - Bristol-Myers SquibbSee more
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis - ALOFT-PPF - Bristol-Myers SquibbSee more
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF) - TETON-PPF - United TherapeuticsSee more
Obesity
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes) - TRIUMPH-OUTCOMES - Eli Lilly and CompanySee more
A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2) - SURMOUNT-ADOLESCENTS-2 - Eli Lilly and CompanySee more
Renal disease
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes) - TRIUMPH-OUTCOMES - Eli Lilly and CompanySee more
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease - NN C0519-0130 - Novo Nordisk A/SSee more
Alopecia
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata - BRAVE-AA-PEDS - Eli Lilly and CompanySee more
Alzheimer disease
A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5) - TRAILBLAZER-ALZ 5 - Eli Lilly and CompanySee more
Asthma
A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma. - EXHALE-2 - Areteia TherapeuticsSee more
Breast Cancer
Study of Belzutifan (MK-6482) Plus Fulvestrant for ER+/HER2- Metastatic Breast Cancer (MK-6482-029/LITESPARK-029) - MK-6482-029 LITESPARK-029 - Merck Sharp & Dohme LLCSee more
Cardiovascular disease
A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) - ACCLAIM-Lp(a) - Eli Lilly and CompanySee more
Dermatitis
A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor - AQUA - SanofiSee more
Diabetes
Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3) - TRANSCEND-T2D-3 - Eli Lilly and CompanySee more
Elevated Lipoprotein A
A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) - ACCLAIM-Lp(a) - Eli Lilly and CompanySee more
Fatty Liver
Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis - Kowa Research Institute, Inc.See more
Fatty liver/nash
Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis - Kowa Research Institute, Inc.See more
Head and neck cancer
A Platform Study of Novel Immunotherapy Combinations as First-Line Treatment in Participants With PD-L1 Positive Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck- GALAXIES H&N-202 - GALAXIES H&N-202 - GlaxoSmithKlineSee more
Heart failure
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure - EASi-HF - Boehringer IngelheimSee more
Lupus
A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus - TOPAZ-2 - BiogenSee more
